Skip to content
TubeRank.
Tesla (TSLA)

The call, on record

TSLA bullish call

Recorded from Randy Kirk’s public commentary. Review the evidence behind the call and its outcome.
TSLABullNot scored: deadline
Randy KirkRandy Kirk

Target Price

$3,300

AI-extracted record · awaiting moderator review. The quote is source evidence; the structured call and thesis are TubeRank’s interpretation.
Quoted text as recorded“I can give you my numbers for 2030 which would include Terapab and which would include Optimus and which would include Solar Fab and which would include the maybe by then the merger you know and we could get to a valuation maybe it's 10 trillion and a stock of 3,300 per share.”

Our interpretation

Source published
Aug 23, 2026
Timeframe
by 2030
Extracted deadline
Dec 31, 2030
Interpreted confidence
low
Specificity
specific

Why this call is unscored

Status
Not scored: deadline
Notes
The stored date is not supported by an unambiguous deadline in the source quote. Horizon labels and extracted dates alone cannot establish a promised window.

How outcomes are decided · Report an error

Email me when TSLA calls resolve

When a tracked TSLA call is scored — hit, miss or partial — we’ll email you the result. No account needed.

Used only for these updates. Privacy

Evidence and source

Our summary of the thesis

Strongly Bullish

Structured interpretation of the video, not a verbatim quotation. Check the source for conditions, emphasis and context.

Randy Kirk argues he remains a buyer of Tesla at current levels because vehicle sales momentum, upcoming unsupervised FSD, Semi ramp, and margin expansion set up a much higher valuation, with robotaxi and Optimus upside not yet priced in. He builds a sum-of-the-parts model stacking auto/energy profits, FSD subscription income, and robotaxi fleet growth to justify a much higher share price than today's.

Key arguments

  • Unsupervised FSD rollout expected in 2027 could cause explosive demand as social sentiment shifts positive
  • Vehicle production capacity increases planned across Texas, Berlin, and Shanghai to push output toward 2.88 million vehicles in 2027
  • Semi truck ramp adds meaningful profit equivalent to multiple average vehicle sales
  • Margins should improve as demand outstrips supply, reducing discounts and incentives
  • Robotaxi and Optimus growth are largely unpriced in current valuation, offering further upside
  • Energy division profit expected to grow 40-50% year over year

Counter-arguments acknowledged

  • Shanghai and Fremont factories appear to be near maximum capacity
  • Cyber cab unit sales will be limited because fleet vehicles do not count as retail sales
  • Significant future growth depends on Texas ramping up production, which is uncertain

Hedges and caveats (from the video)

  • Barring a negative shock
  • Personal buying restricted for 4 months due to family decision-making process
  • Production capacity limited to approximately 500,000 cars per quarter
  • FSD unsupervised rollout timeline uncertain despite being described as 'incredibly close'

About this record

Not yet reviewed by a moderator

AI-extracted record. A quote, summary and outcome each need their own context. Moderator review does not certify investment performance.

Source published
Aug 23, 2026, 3:33 PM UTC
First recorded by TubeRank
Aug 24, 2026, 12:23 PM UTC
Record last updated
Oct 6, 2026, 6:32 AM UTC
Moderator review recorded
Not recorded
Transcript provenance
YouTube captions (manual or automatic)
Recorded analysis processor/source label
claude-sonnet-5
This can identify a workflow rather than an exact AI model version.
Extraction pipeline version
v1.0.0
Outcome methodology version
2026-10-06.5
Outcome reason code
unverified_stated_deadline
Publication is when the video was released; recording is when TubeRank added this call. They are not interchangeable. Legacy records can lack version and observation metadata. Dates are shown in UTC.
Recent record changes 4 shown
  1. Oct 6, 2026, 6:32 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.4

    After2026-10-06.5

  2. Oct 6, 2026, 5:14 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.2

    After2026-10-06.4

  3. Oct 6, 2026, 4:00 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.1

    After2026-10-06.2

  4. Oct 6, 2026, 3:27 AM UTC

    unverified stated deadline

    Outcome methodology version

    BeforeNot recorded

    After2026-10-06.1

    Recorded outcome date

    BeforeNot recorded

    After2026-10-06

    Outcome explanation

    BeforeNot recorded

    AfterThe stored date is not supported by an unambiguous deadline in the source quote. Horizon labels and extracted dates alone cannot establish a promised window.

    Outcome reason

    BeforeNot recorded

    AfterUnverified stated deadline

    Outcome status

    Beforepending

    Afterunverifiable

Showing up to 20 recent changes. The complete feed has 5 recorded events for this call, including its initial entry. Read the full paginated history (JSON); follow nextCursor while hasMore is true.

Stored outcome evidence
Stored reference price
Not recorded
Not recorded · provider not recorded
Target as extracted
$3,300
Stated deadline as extracted
Dec 31, 2030
Recorded outcome date
Oct 6, 2026
Outcome price observation
Not recorded
Not recorded · provider not recorded

Stored explanation

The stored date is not supported by an unambiguous deadline in the source quote. Horizon labels and extracted dates alone cannot establish a promised window.

Missing timestamps, providers and versions are historical gaps. Stored observations can include daily closes; they do not show every intraday touch or prove an executable trade. Read the methodology.

Why we interpreted the confidence this way

Heavily hedged with 'maybe' and 'could', and dependent on multiple speculative future businesses (Terapab, Optimus, Solar Fab, a merger) all materializing.